News & analysis on the clinical development and manufacture of large molecule drugs
Hired and Retired: Pharma C-suites see new faces
By Maggie Lynch
- Last updated on
While last month saw many pharma executives leaving their positions to head towards smaller biotech companies, this month saw members of the industry climbing the ladder from all different starting points.
Clinigen’s C-suite will have a former pharmacist turned qualified account heading up financial matters, and bio-technology companies like Oxford Genetics will be bolstered by experienced managers.